Cargando…
Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia
The American Trial Using Tranexamic Acid (TXA) in Thrombocytopenia (A-TREAT, NCT02578901) demonstrated no superiority of TXA over placebo in preventing World Health Organization (WHO) grade 2 or higher bleeding in patients with severe thrombocytopenia requiring supportive platelet transfusion follow...
Autores principales: | Ilich, Anton, Gernsheimer, Terry B., Triulzi, Darrell J., Herren, Heather, Brown, Siobhan P., Holle, Lori A., Lucas, Andrew T., de Laat, Bas, El Kassar, Nahed, Wolberg, Alisa S., May, Susanne, Key, Nigel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025092/ https://www.ncbi.nlm.nih.gov/pubmed/36044391 http://dx.doi.org/10.1182/bloodadvances.2022008255 |
Ejemplares similares
-
A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation
por: Wan, Jun, et al.
Publicado: (2022) -
The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis
por: Hsu, Charles, et al.
Publicado: (2022) -
The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia
por: Bissola, Anna-Lise, et al.
Publicado: (2022) -
Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia
por: Tuleja, Aleksandra, et al.
Publicado: (2022) -
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy
por: Cordero-Sanchez, Celia, et al.
Publicado: (2022)